CGT Catapult says its venture into Edinburgh, Scotland and northern England will focus on the development and production of induced pluripotent stem cells (iPSCs). The Cell and Gene Therapy Catapult (CGT Catapult) announced in June 2021 that it would construct offices and laboratories in Edinburgh, Scotland to support the cell and gene therapy sector and drive product development but did not disclose a specific modality. Now, the organization has confirmed to BioProcess Insider that its move to create a cluster…